Estradiol acutely inhibits whole body lipid oxidation and attenuates lipolysis in subcutaneous adipose tissue: A randomized, placebo-controlled study in postmenopausal women

European Journal of Endocrinology

Volumn 167, Issue 4, 2012, Pages 543-551

  Gormsen, Lars Christian ^a   Høst, Christian ^a   Hjerrild, Britta Eilersen ^a   Pedersen, Steen Bønløkke ^a   Nielsen, Søren ^a   Christiansen, Jens Sandahl ^a   Gravholt, Claus Højbjerg ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; CATECHOLAMINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; GLYCEROL; LIPOPROTEIN LIPASE; MESSENGER RNA; PLACEBO;

ABDOMINAL FAT; ADIPOSE TISSUE BLOOD FLOW; ADULT; ARTICLE; BODY MASS; CALORIMETRY; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; LIPID METABOLISM; LIPID OXIDATION; LIPOLYSIS; MICRODIALYSIS; MUSCLE BIOPSY; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; SKELETAL MUSCLE; SUBCUTANEOUS FAT; UPREGULATION;

CROSS-OVER STUDIES; DOWN-REGULATION; ESTRADIOL; FEMALE; HEMODYNAMICS; HUMANS; LIPID METABOLISM; LIPOLYSIS; MIDDLE AGED; OXIDATION-REDUCTION; PLACEBOS; POSTMENOPAUSE; SINGLE-BLIND METHOD; SUBCUTANEOUS FAT; TIME FACTORS;

EID: 84866644831     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0422     Document Type: Article

References (44)

1. Sack MN, Rader DJ & Cannon RO III. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994 343 269-270. (doi:10.1016/S0140-6736(94)91117-7)
2. Collins P, Rosano GM, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, McNeill JG & Poole-Wilson PA. 17β-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995 92 24-30. (doi:10.1161/01.CIR.92.1.24)
3. Gilligan DM, Badar DM, Panza JA, Quyyumi AA & Cannon RO III. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994 90 786-791. (doi:10.1161/01.CIR.90.2.786)
4. Losordo DW, Kearney M, Kim EA, Jekanowski J & Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994 89 1501-1510. (doi:10.1161/01.CIR.89.4.1501)
5. Selzman CH, Gaynor JS, Turner AS, Johnson SM, Horwitz LD, Whitehill TA & Harken AH. Ovarian ablation alone promotes aortic intimal hyperplasia and accumulation of fibroblast growth factor. Circulation 1998 98 2049-2054. (doi:10.1161/01.CIR.98.19.2049)
6. Terauchi M, Honjo H, Mizunuma H & Aso T. Effects of oral estradiol and levonorgestrel on cardiovascular risk markers in postmenopausal women. Archives of Gynecology and Obstetrics 2012 285 1647-1656. (doi:10.1007/s00404- 012-2222-9)
7. Gaspard UJ, Wery OJ, Scheen AJ, Jaminet C & Lefebvre PJ. Long-term effects of oral estradiol and dydrogesterone on carbohydrate metabolism in postmenopausalwomen. Climacteric 1999 2 93-100. (doi:10.3109/13697139909025572)
8. Simpson ER, Misso M, Hewitt KN, Hill RA, Boon WC, Jones ME, Kovacic A, Zhou J & Clyne CD. Estrogen - the good, the bad, and the unexpected. Endocrine Reviews 2005 26 322-330. (doi:10.1210/er.2004-0020)
9. Rutherford OM & Jones DA. The relationship of muscle and bone loss and activity levels with age in women. Age and Ageing 1992 21 286-293. (doi:10.1093/ageing/21.4.286)
10. Phillips SK, Rook KM, Siddle NC, Bruce SA & Woledge RC. Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clinical Science 1993 84 95-98.
11. Haarbo J, Marslew U, Gotfredsen A & Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991 40 1323-1326. (doi:10.1016/0026-0495(91)90037-W)
12. Rader DJ. Effect of insulin resistance, dyslipidemia, and intraabdominal adiposity on the development of cardiovascular disease and diabetes mellitus. American Journal of Medicine 2007 120 S12-S18. (doi:10.1016/j.amjmed.2007.01. 003)
13. Elbers JM, de Jong S, Teerlink T, Asscheman H, Seidell JC &Gooren LJ. Changes in fat cell size and in vitro lipolytic activity of abdominal and gluteal adipocytes after a one-year cross-sex hormone administration in transsexuals. Metabolism 1999 48 1371-1377. (doi:10.1016/S0026-0495(99)90146-4)
14. Jensen MD, Martin ML, Cryer PE & Roust LR. Effects of estrogen on free fatty acid metabolism in humans. American Journal of Physiology. Endocrinology and Metabolism 1994 266 E914-E920.
15. Pedersen SB, Kristensen K, Hermann PA, Katzenellenbogen JA &Richelsen B. Estrogen controls lipolysis by up-regulating α2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor a. Implications for the female fat distribution. Journal of Clinical Endocrinology and Metabolism 2004 89 1869-1878. (doi:10.1210/jc.2003-031327)
16. Lindberg UB, Crona N, Silfverstolpe G, Bjorntorp P & Rebuffe-Scrive M. Regional adipose tissue metabolism in postmenopausal women after treatment with exogenous sex steroids. Hormone and Metabolic Research 1990 22 345-351. (doi:10.1055/s-2007-1004917)
17. Van Pelt RE, Gozansky WS, Hickner RC, Schwartz RS & Kohrt WM. Acute modulation of adipose tissue lipolysis by intravenous estrogens. Obesity 2006 14 2163-2172. (doi:10.1038/oby.2006.253)
18. 2 effects on p42/p44 MAPK, activator protein-1, and cAMP response element binding protein in rat white adipocytes. Endocrinology 2002 143 930-940. (doi:10.1210/en.143.3.930)
19. Gormsen LC, Host C, Hjerrild BE, Gravholt CH & Nielsen S. Acute estrogen exposure does not affect basal very low-density lipoprotein - triglyceride production or oxidation in post-menopausal women. European Journal of Endocrinology 2010 163 421-426. (doi:10.1530/EJE-10-0551)
20. Stich V, Pelikanova T, Wohl P, Sengenes C, Zakaroff-Girard A, Lafontan M & Berlan M. Activation of α2-adrenergic receptors blunts epinephrine-induced lipolysis in subcutaneous adipose tissue during a hyperinsulinemic euglycemic clamp in men. American Journal of Physiology. Endocrinology and Metabolism 2003 85 E599-E607.
21. Stallknecht B, Simonsen L, Bulow J, Vinten J & Galbo H. Effect of training on epinephrine-stimulated lipolysis determined by microdialysis in human adipose tissue. American Journal of Physiology. Endocrinology and Metabolism 1995 269 E1059-E1066.
22. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. Journal of Applied Physiology 1983 55 628-634.
23. Lonnroth P & Strindberg L. Validation of the 'internal reference technique' for calibrating microdialysis catheters in situ. Acta Physiologica Scandinavica 1995 153 375-380. (doi:10.1111/j.1748-1716.1995.tb09875.x)
24. Arner P & Bolinder J. Microdialysis of adipose tissue. Journal of Internal Medicine 1991 230 381-386. (doi:10.1111/j.1365-2796.1991.tb00461.x)
25. Hagstrom-Toft E, Enoksson S, Moberg E, Bolinder J & Arner P. Absolute concentrations of glycerol and lactate in human skeletal muscle, adipose tissue, and blood. American Journal of Physiology 1997 273 E584-E592.
26. Jansson PA, Smith U & Lonnroth P. Interstitial glycerol concentration measured by microdialysis in two subcutaneous regions in humans. American Journal of Physiology. Endocrinology and Metabolism 1990 258 E918-E922.
27. Larsen OA, Lassen NA & Quaade F. Blood flow through human adipose tissue determined with radioactive xenon. Acta Physiologica Scandinavica 1966 66 337-345. (doi:10.1111/j.1748-1716.1966.tb03208.x)
28. Bulow J, Jelnes R, Astrup A, Madsen J & Vilmann P. Tissue/blood partition coefficients for xenon in various adipose tissue depots in man. Scandinavian Journal of Clinical and Laboratory Investigation 1987 47 1-3.
29. Hietanen E & Greenwood MR. A comparison of lipoprotein lipase activity and adipocyte differentiation in growing male rats. Journal of Lipid Research 1977 18 480-490.
30. Pedersen SB, Bruun JM, Kristensen K & Richelsen B. Regulation of UCP1, UCP2, and UCP3 mRNA expression in brown adipose tissue, white adipose tissue, and skeletal muscle in rats by estrogen. Biochemical and Biophysical Research Communications 2001 288 191-197. (doi:10.1006/bbrc.2001.5763)
31. Carstensen E & Yudkin JS. Platelet catecholamine concentrations after short-term stress in normal subjects. Clinical Science 1994 86 35-41.
32. Ley CJ, Lees B & Stevenson JC. Sex- and menopause-associated changes in body-fat distribution. American Journal of Clinical Nutrition 1992 55 950-954.
33. Price TM & O'Brien SN. Determination of estrogen receptor messenger ribonucleic acid (mRNA) and cytochrome P450 aromatase mRNA levels in adipocytes and adipose stromal cells by competitive polymerase chain reaction amplification. Journal of Clinical Endocrinology and Metabolism 1993 77 1041-1045. (doi:10.1210/jc.77.4.1041)
34. Van Pelt RE, Gozansky WS, Schwartz RS & Kohrt WM. Intravenous estrogens increase insulin clearance and action in postmenopausal women. American Journal of Physiology. Endocrinology and Metabolism 2003 285 E311-E317.
35. Arner P. Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Practice & Research. Clinical Endocrinology &Metabolism 2005 19 471-482. (doi:10.1016/j.beem.2005.07.004)
36. dos Reis CM, de Melo NR, Meirelles ES, Vezozzo DP & Halpern A. Body composition, visceral fat distribution and fat oxidation in postmenopausal women using oral or transdermal oestrogen. Maturitas 2003 46 59-68. (doi:10.1016/S0378-5122(03)00159-2)
37. Lwin R, Darnell B, Oster R, Lawrence J, Foster J, Azziz R &Gower BA. Effect of oral estrogen on substrate utilization in postmenopausal women. Fertility and Sterility 2008 90 1275-1278. (doi:10.1016/j.fertnstert.2007.07. 1317)
38. O'Sullivan AJ, Crampton LJ, Freund J & Ho KK. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women. Journal of Clinical Investigation 1998 102 1035-1040. (doi:10.1172/JCI2773)
39. O'Sullivan AJ, Hoffman DM & Ho KK. Estrogen, lipid oxidation, and body fat. New England Journal of Medicine 1995 333 669-670. (doi:10.1056/ NEJM199509073331018)
40. Huang DS & O'Sullivan AJ. Short-term oral oestrogen therapy dissociates the growth hormone/insulin-like growth factor-I axis without altering energy metabolism in premenopausal women. Growth Hormone & IGF Research 2009 19 162-167. (doi:10.1016/j.ghir.2008.08.009)
41. Gower BA, Nagy TR, Blaylock ML, Wang C & Nyman L. Estradiol may limit lipid oxidation via Cpt 1 expression and hormonal mechanisms. Obesity Research 2002 10 167-172. (doi:10.1038/oby.2002.26)
42. Samra JS, Simpson EJ, Clark ML, Forster CD, Humphreys SM, Macdonald IA & Frayn KN. Effects of epinephrine infusion on adipose tissue: interactions between blood flow and lipid metabolism. American Journal of Physiology. Endocrinology and Metabolism 1996 271 E834-E839.
43. Gonzales RJ, Walker BR & Kanagy NL. 17β-Estradiol increases nitric oxide-dependent dilation in rat pulmonary arteries and thoracic aorta. American Journal of Physiology. Lung Cellular and Molecular Physiology 2001 280 L555-L564.
44. Zerr-Fouineau M, Jourdain M, Boesch C, Hecker M, Bronner C &Schini-Kerth VB. Certain progestins prevent the enhancing effect of 17β-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 586-593. (doi:10.1161/ATVBAHA.108.178004)